MDM2 SNP309 is an ethnicity-dependent risk factor for digestive tract cancers
Autor: | Lei Cao, Maoming Xiong, Kong-Wang Hu, Xiang-Ling Meng, Jiawei Zhang, Bo Chen |
---|---|
Rok vydání: | 2013 |
Předmět: |
medicine.medical_specialty
Genotype Stomach Proto-Oncogene Proteins c-mdm2 General Medicine Odds ratio Biology Digestive System Neoplasms Genes p53 medicine.disease Polymorphism Single Nucleotide Gastroenterology medicine.anatomical_structure Risk Factors Internal medicine Pancreatic cancer Genetic model medicine Humans Genetic Predisposition to Disease Esophagus Pancreas Stomach cancer |
Zdroj: | Tumor Biology. 35:3431-3438 |
ISSN: | 1423-0380 1010-4283 |
DOI: | 10.1007/s13277-013-1453-0 |
Popis: | Published data on the relationship between T309G polymorphism in the murine double minute 2 (MDM2) gene and susceptibility of digestive tract cancers (DTC) are inconclusive. Thus, the aim of this study is to determine whether MDM2 T309G polymorphism is associated with the risk of diverse DTC, including esophagus, stomach, liver, bile duct, pancreas, and colorectum cancers. Relevant studies were identified up to October 1, 2013. Crude odds ratio (OR) and 95% confidence interval (CI) were used as a measure of the strength of the association. The pooled result based on all studies showed that there was a statistically significant link between MDM2 T309G polymorphism and DTC susceptibility (T vs. G: OR = 0.82, 95%CI = 0.76-0.88). When stratified by race, significant associations were observed for all genetic models among Asians (especially in Chinese population), but not among Caucasians. Subgroup analyses according to tumor location indicated that the genetic variant was associated with esophageal (OR = 0.88, 95%CI = 0.81-0.96 for T vs. G), hepatocellular (OR = 0.69, 95%CI = 0.57-0.84 for T vs. G) and pancreatic cancer risk but not associated with cholangiocarcinoma or colorectum cancer susceptibility. Meanwhile, the G allele was also suggested to be associated with increased gastric cancer risk (OR = 0.68, 95%CI = 0.54-0.87 for TT + TG vs. GG for intestinal type of gastric cancer and OR = 0.18, 95%CI = 0.06-0.50 for TT vs. GG for Helicobacter pylori infection positive stomach cancer). Our study indicates that the MDM2 T309G polymorphism may be an ethnicity-dependent risk factor for DTC, especially for the upper gastrointestinal tract malignancies. |
Databáze: | OpenAIRE |
Externí odkaz: |